Literature DB >> 23806228

Immunosuppression effects on airway mucociliary clearance: comparison between two triple therapies.

Maristela Prado e Silva1, Sônia F Soto, Francine M Almeida, Tatiana T K Limonete, Edwin R C Parra, Fabio B Jatene, Paulo M Pêgo-Fernandes, Rogerio Pazetti.   

Abstract

BACKGROUND: Tacrolimus and mycophenolate have now become the most widely used combination for maintenance immunosuppressive regimens after lung transplantation in comparison with cyclosporine and azathioprine. However, limited information is available with respect to their effects on cells, other than those from the immunologic compartment. We hypothesized that different triple therapies could have different effects on airway mucociliary clearance, playing an important role in respiratory infections observed after lung transplantation.
METHODS: Ninety rats were assigned to three groups (n = 30 each): control = vehicle, therapy 1 = tacrolimus + mycophenolate + prednisone, and therapy 2 = cyclosporine + azathioprine + prednisone. After 7, 15, or 30 days of treatment by gavage, the animals were killed and the following parameters were studied: mucus transportability, ciliary beating frequency, mucociliary transport velocity, and neutral and acid mucus production.
RESULTS: There was a significant decrease in ciliary beating frequency, mucociliary transport velocity, and neutral mucus production in all immunosuppressed animals; indeed, both therapies, mainly therapy 1, caused an increase in acid mucus production for as long as 15 days of treatment.
CONCLUSIONS: Both triple therapies impaired airway mucociliary clearance of rats, but therapy 1 had a more deleterious effect. These data suggest that these undesirable effects can contribute to the high incidence of respiratory infections observed in patients undergoing lung transplantation.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  12

Mesh:

Substances:

Year:  2013        PMID: 23806228     DOI: 10.1016/j.athoracsur.2013.04.069

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

2.  Basiliximab Does Not Impair Airway Mucociliary Clearance of Rats.

Authors:  Aristides Tadeu Correia; Francine Maria de Almeida; Marcia Cristina Augusto-Cottet; Patrícia Nolasco; Afonso Silva Alves Bento; Hugo Kenji Matsushima Hirano; Maria Cecília Ribeiro de Souza; Elizabete Silva Dos Santos; Júlia Helena Rodrigues de Castro; Monique Matsuda; Paulo Manuel Pêgo-Fernandes; Rogerio Pazetti
Journal:  Inflammation       Date:  2022-06-17       Impact factor: 4.092

3.  The effects of individually ventilated cages on the respiratory systems of male and female Wistar rats from birth until adulthood.

Authors:  Guilherme D'Aprile Marchesi; Sônia de Fatima Soto; Isac de Castro; Thiago Guimarães Rodrigues; Henrique Takachi Moriya; Francine Maria de Almeida; Rogerio Pazetti; Joel Claudio Heimann; Luzia Naôko Shinohara Furukawa
Journal:  Clinics (Sao Paulo)       Date:  2017-03       Impact factor: 2.365

4.  Airway cilia recovery post lung transplantation.

Authors:  Randy Suryadinata; Kovi Levin; Lynda Holsworth; Miranda Paraskeva; Philip Robinson
Journal:  Immun Inflamm Dis       Date:  2021-09-21

5.  Building a Lung Transplant Program.

Authors:  Marcos Naoyuki Samano; Paulo Manuel Pêgo-Fernandes
Journal:  Clinics (Sao Paulo)       Date:  2015-12       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.